FONR
Fonar CorporationNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$118.97M
P/E Ratio
18.89
EPS
$1.00
Beta
0.96
52W High
$18.95
52W Low
$13.62
50-Day MA
$18.72
200-Day MA
$16.89
Dividend Yield
—
Profit Margin
6.35%
Forward P/E
10.88
PEG Ratio
0.00
About Fonar Corporation
FONAR Corporation is engaged in the research, development, production, and marketing of Magnetic Resonance Imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company is headquartered in Melville, New York.
Fundamentals
| Revenue (TTM) | $105.34M |
| Gross Profit (TTM) | $42.41M |
| EBITDA | $13.76M |
| Operating Margin | 9.23% |
| Return on Equity | 5.47% |
| Return on Assets | 2.74% |
| Revenue/Share (TTM) | $16.08 |
| Book Value | $27.01 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | 1.13 |
| EV/Revenue | 0.99 |
| EV/EBITDA | 6.52 |
| Quarterly Earnings Growth (YoY) | -37.10% |
| Quarterly Revenue Growth (YoY) | -2.60% |
| Shares Outstanding | $6.17M |
| Float | $5.77M |
| % Insiders | 11.36% |
| % Institutions | 40.34% |
Historical Volatility
HV 10-Day
2.15%
HV 20-Day
2.12%
HV 30-Day
2.03%
HV 60-Day
3.38%
HV Rank
0.4%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026